Juventas Cell Therapy Ltd.
Clinical trials sponsored by Juventas Cell Therapy Ltd., explained in plain language.
-
New cell therapy tested for patients with rare, Treatment-Resistant blood disorder
Disease control Not yet recruitingThis is an early-stage study to test the safety and find the right dose of a new cell therapy called Inaticabtagene Autoleucel for people with autoimmune hemolytic anemia (AIHA). The study will enroll up to 12 adults in China whose AIHA has not improved after trying at least thre…
Phase: PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New cell therapy tested for Tough-to-Treat brain and nerve autoimmune disorders
Disease control Not yet recruitingThis is an early, small study to see if a new cell-based injection called HY001N is safe and might help people with certain autoimmune diseases that affect the brain and nerves, and have come back or not responded to other treatments. It will enroll about 15 adults with condition…
Phase: EARLY_PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC